42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-1041475
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => c4c747cc-4b09-4d22-9abc-6f1be3a51db6
[Document ID] => 1041475
[Document naam] => 02-COVID-Villafana_AstraZeneca.pdf
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/document/VWS-WOO-08-1041475
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-1041475
[Status] =>
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo
[DocumentPublicationDate] => 27 januari 2021
[DocumentStatusCheckedDate] =>
[DocumentStatusCheckedResult] =>
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 05:30:44
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 05:30:44
)
Document: VWS-WOO-08-1041475
Klik om te vergroten
Document correcties
Geregistreerde datum: 20210127
Geregistreerde documentnaam: 02-COVID-Villafana_AstraZeneca.pdf
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| document_SectionHistory | 1 | 2025-06-22 23:41:09 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 19 december 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode januari 2021. | 2025-06-22 23:41:09 |
| Request_Periode | Januari 2021 | 2025-06-22 23:41:09 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:41:09 |
| Request_Datum besluit | 19 december 2022 | 2025-06-22 23:41:09 |
| Request_Omvang openbaarmaking | 15.371 documenten, 25.508 pagina's Inventarislijst | 2025-06-22 23:41:09 |
| Request_Omvang openbaarmaking_documenten | 15.371 | 2025-06-22 23:41:09 |
| Request_Omvang openbaarmaking_paginas | 25.508 | 2025-06-22 23:41:09 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/file/download/inventory | 2025-06-22 23:41:09 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:41:09 |
| document_documentName | 02-COVID-Villafana_AstraZeneca.pdf | 2025-06-22 23:41:09 |
| document_documentType | 2025-06-22 23:41:09 | |
| document_documentPublicationDate | 2021-01-27 | 2025-06-22 23:41:09 |
| document_documentNumber | VWS-WOO-08-1041475 | 2025-06-22 23:41:09 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:41:09 |
| document_SectionHTMLDataDivs | 3 | 2025-06-22 23:41:09 |
| document_SectionAbout | 1 | 2025-06-22 23:41:09 |
| About_Datum document | 27 januari 2021 | 2025-06-22 23:41:09 |
| About_Type bronbestand | PDF, 33 pagina's | 2025-06-22 23:41:09 |
| About_Type bronbestand_paginas | 33 | 2025-06-22 23:41:09 |
| About_Download als | PDF (10.25 MB) | 2025-06-22 23:41:09 |
| About_Documentnummer | 1041475 | 2025-06-22 23:41:09 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:41:09 |
| About_Gelakte gegevens | 5.1.1c Vertrouwelijk verstrekte bedrijfs- of fabricagegegevens 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:41:09 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:41:09 |
| About_Gelakte gegevens_linkname_1 | 5.1.1c Vertrouwelijk verstrekte bedrijfs- of fabricagegegevens | 2025-06-22 23:41:09 |
| About_Gelakte gegevens_linkhref_2 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:41:09 |
| About_Gelakte gegevens_linkname_2 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:41:09 |
| About_Gelakte gegevens_linkhref_3 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over 02-COVID-Villafana_AstraZeneca.pdf (documentnummer 1ee694c0-25c3-6184-aef3-b5de068c5498) | 2025-06-22 23:41:09 |
| About_Gelakte gegevens_linkname_3 | Laat het ons weten | 2025-06-22 23:41:09 |
| document_SectionRequest | 1 | 2025-06-22 23:41:09 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode januari 2021 | 2025-06-22 23:41:09 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo | 2025-06-22 23:41:09 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode januari 2021 | 2025-06-22 23:41:09 |
| History Datum_1 | 19 augustus 2024 12:11 | 2025-06-21 03:55:05 |
| History Datum_2 | 16 augustus 2024 14:00 | 2025-06-21 03:55:05 |
| History Actie_2 | Bronbestand toegevoegd (pdf, 10.25 MB) | 2025-06-21 03:55:05 |
| History Datum_3 | 16 augustus 2024 13:52 | 2025-06-21 03:55:05 |
| History Actie_3 | Opschorting opgeheven | 2025-06-21 03:55:05 |
| History Actie_1 | Bronbestand vervangen (pdf, 10.25 MB) | 2025-06-21 03:55:05 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3477674-1040721-pdo/file/download/document/1ee694c0-25c3-6184-aef3-b5de068c5498 | 2025-04-19 22:58:20 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-1041475.pdf | 2025-04-19 22:58:20 |
| DocumentDownload_linkname | Download (pdf, 10.25 MB) | 2025-04-19 22:58:20 |
Archiefversies (7 rijen)
Archiefrij 1 — 2025-09-07 17:23:04
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1041475.pdf
documentName: VWS-WOO-08-1041475.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 10749533
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:23:04
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:23:04
lastSeen: 2025-09-07 17:23:04
text: 1041475
Astrazeneca
AstraZeneca COVID-19
Vaccine
(AZD1222)
ACIP COVID-19 Emergency Meeting
January 27,2021Forward-Looking Statements
Inorder, among other things,toutilize the 'safe harbor’ provisions oftheUSPrivate Securities Litigation Reform Act of1995, AstraZeneca
(hereafter "theGroup)provides th...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 2757420c44c46d1077227d564ba188427b01152ef1b357d89988d29915597cdd
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: folder_import_35260_a4b54b1af9e4ecfb01120a9d63e8abfe
textDigestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1041475
Archiefrij 2 — 2025-09-04 17:03:04
fromFile: VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip
documentName: VWS-WOO-08-1041475.pdf
documentType: pdf
documentCompressedSize: 6122556
documentSize: 10749533
documentCompressRatio: 56.95648359793862
documentDateModified: 2025-05-01 20:42:50
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:03:04
lastSeen: 2025-09-04 17:03:04
text: 1041475
Astrazeneca
AstraZeneca COVID-19
Vaccine
(AZD1222)
ACIP COVID-19 Emergency Meeting
January 27,2021Forward-Looking Statements
Inorder, among other things,toutilize the 'safe harbor’ provisions oftheUSPrivate Securities Litigation Reform Act of1995, AstraZeneca
(hereafter "theGroup)provides th...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 2757420c44c46d1077227d564ba188427b01152ef1b357d89988d29915597cdd
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip_3485
textDigestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1041475
Archiefrij 3 — 2025-03-18 09:30:25
fromFile: 2024.075-VWS-WOO-3477674-1040721-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3477674-1040721-pdo.zip
documentName: VWS-WOO-08-1041475-02-COVID-Villafana_AstraZeneca.pdf
documentType: pdf
documentCompressedSize: 6109464
documentSize: 10749533
documentCompressRatio: 56.83469226058472
documentDateModified: 2024-11-14 10:46:52
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:25
lastSeen: 2025-03-18 09:30:25
text: 1041475
Astrazeneca
AstraZeneca COVID-19
Vaccine
(AZD1222)
ACIP COVID-19 Emergency Meeting
January 27,2021Forward-Looking Statements
Inorder, among other things,toutilize the 'safe harbor’ provisions oftheUSPrivate Securities Litigation Reform Act of1995, AstraZeneca
(hereafter "theGroup)provides th...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 328555
textDigestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1041475
Archiefrij 4 — 2025-02-27 09:25:05
fromFile: 2023.057-VWS-WOO-3477674-1040721-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3477674-1040721-pdo.zip
documentName: VWS-WOO-08-1041475-02-COVID-Villafana_AstraZeneca.pdf
documentType: pdf
documentCompressedSize: 6109464
documentSize: 10749533
documentCompressRatio: 56.83469226058472
documentDateModified: 2024-11-14 10:46:52
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:05
lastSeen: 2025-02-27 09:25:05
text: 1041475
Astrazeneca
AstraZeneca COVID-19
Vaccine
(AZD1222)
ACIP COVID-19 Emergency Meeting
January 27,2021Forward-Looking Statements
Inorder, among other things,toutilize the 'safe harbor’ provisions oftheUSPrivate Securities Litigation Reform Act of1995, AstraZeneca
(hereafter "theGroup)provides th...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 241643
textDigestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1041475
Archiefrij 5 — 2025-02-18 12:18:13
fromFile: Besluit__dossier_nr_-7b96e539f6d667469c9ac30d7d6532aa0289bb878a63cc17383edcca0c24d48d.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-7b96e539f6d667469c9ac30d7d6532aa0289bb878a63cc17383edcca0c24d48d.zip
documentName: VWS-WOO-08-1041475-02-COVID-Villafana_AstraZeneca.pdf
documentType: pdf
documentCompressedSize: 6109464
documentSize: 10749533
documentCompressRatio: 56.83469226058472
documentDateModified: 2024-11-14 10:46:52
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: 1041475
Astrazeneca
AstraZeneca COVID-19
Vaccine
(AZD1222)
ACIP COVID-19 Emergency Meeting
January 27,2021Forward-Looking Statements
Inorder, among other things,toutilize the 'safe harbor’ provisions oftheUSPrivate Securities Litigation Reform Act of1995, AstraZeneca
(hereafter "theGroup)provides th...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 111267
textDigestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1041475
Archiefrij 6 — 2025-02-18 12:18:04
fromFile: Besluit__dossier_nr_-56dedcf3b5a6fd477519d5eceba72bb3d95085d3ef569f0f6cb8c5110cd5ac60.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-56dedcf3b5a6fd477519d5eceba72bb3d95085d3ef569f0f6cb8c5110cd5ac60.zip
documentName: VWS-WOO-08-1041475-02-COVID-Villafana_AstraZeneca.pdf
documentType: pdf
documentCompressedSize: 6109464
documentSize: 10749533
documentCompressRatio: 56.83469226058472
documentDateModified: 2024-10-31 16:01:22
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:04
lastSeen: 2025-02-18 12:18:04
text: 1041475
Astrazeneca
AstraZeneca COVID-19
Vaccine
(AZD1222)
ACIP COVID-19 Emergency Meeting
January 27,2021Forward-Looking Statements
Inorder, among other things,toutilize the 'safe harbor’ provisions oftheUSPrivate Securities Litigation Reform Act of1995, AstraZeneca
(hereafter "theGroup)provides th...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 64935
textDigestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1041475
Archiefrij 7 — 2025-02-18 12:17:59
fromFile: Besluit__dossier_nr_-571f1ae5b0d04da300d026d2496e833b604aa1615f95ba2726b608e5251d62aa.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-571f1ae5b0d04da300d026d2496e833b604aa1615f95ba2726b608e5251d62aa.zip
documentName: VWS-WOO-08-1041475-02-COVID-Villafana_AstraZeneca.pdf
documentType: pdf
documentCompressedSize: 6109464
documentSize: 10749533
documentCompressRatio: 56.83469226058472
documentDateModified: 2024-08-19 14:16:02
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:17:59
lastSeen: 2025-02-18 12:17:59
text: 1041475
Astrazeneca
AstraZeneca COVID-19
Vaccine
(AZD1222)
ACIP COVID-19 Emergency Meeting
January 27,2021Forward-Looking Statements
Inorder, among other things,toutilize the 'safe harbor’ provisions oftheUSPrivate Securities Litigation Reform Act of1995, AstraZeneca
(hereafter "theGroup)provides th...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 5032
textDigestSHA256: 9b87a439efc5e60fcae8af6c70977cda99de86a80861a0b30b72f1202e47b39b
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1041475
(dit is ook een speeltuin)